Medtronic Evolut

TAVI: Medtronic launches U.S. trial for CoreVal...

FDA approves revised labelling for Medtronic’s ...

Medtronic launches off two new studies evaluati...

Medtronic wins expanded CE Mark for Evolut R TA...

Medtronic begins SMART trial, and feasility stu...

Medtronic Cardiac and Vascular on LinkedIn: 🔎 ...

Medtronic Vascular D-EVOLUTFX-2329 box of 1... ...

Medtronic wins CE mark for Evolut TAVR system i...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

TAVI: FDA approves Medtronic's CoreValve Evolut...

CIS & Terrebonne General are First in Louisiana...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

Medtronic - Evolut R System Transcatheter Aorti...

SMART trial one-year data demonstrates Medtroni...

Medtronic - Evolut R System Transcatheter Aorti...

Study: Medtronic Evolut TAVR Platform Outperfor...

Medtronic gets expanded CE mark for Evolut TAVI...

Complete Two-Year Data Confirms That Medtronic'...

Medtronic Vascular, D-EVPROP2329US, Medtronic E...

Medtronic - Evolut R System Transcatheter Aorti...

Medtronic Cardiac and Vascular on LinkedIn: Key...

Medtronic announces FDA approval of newest-gene...

New MEDTRONIC D-EVOLUTFX-2329 Evolut FX Deliver...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

Medtronic Timeline

Medtronic Timeline

Medtronic News - Business & regional news

Medtronic Cardiac and Vascular on LinkedIn: Pat...

Medtronic PLC (NYSE:MDT) Soars With The Approva...

Medtronic announces FDA approval of newest-gene...

Medtronic launches new Evolut TAVR System in US

Excellent outcomes for Medtronic Evolut TAVR in...

Medtronic has positive Evolut TAVR data

Medtronic secures CE mark for Evolut FX TAVI sy...